Anemia in Myelodysplastic Syndromes
3 clinical trials · Condition
◉ Watch Anemia in Myelodysplastic Syndromes
| Record | Firm | Date |
|---|---|---|
| A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia (NCT07052006) | Halia Therapeutics, Inc. | 2023-12-09 |
| A Study of TP-0184 to Treat Anemia in Adults With IPSS-R Low or Intermediate Risk MDS (NCT04623996) | Sumitomo Pharma America, Inc. | 2020-12-28 |
| Treatment of the Anemia of Myelodysplastic Syndromes by the Association of Epoetin Beta and All Trans Retinoic Acid (NCT00437450) | Groupe Francophone des Myelodysplasies | 2004-10-01 |
Track Anemia in Myelodysplastic Syndromes automatically
Every clearance here is in the API, with alerts when new ones post.